Ballast Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $36K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $7.02K | Hold |
|
|||||
|
2023
Q4 | $6.61K | Sell |
|
|||||
|
2023
Q3 | $9.13K | Sell |
|
|||||
|
2023
Q2 | $55.2K | Sell |
|
|||||
|
2023
Q1 | $73K | Buy |
|
|||||
|
2022
Q4 | $61.3K | Hold |
|
|||||
|
2022
Q3 | $59K | Hold |
|
|||||
|
2022
Q2 | $55K | Buy |
|
|||||
|
2022
Q1 | $65K | Sell |
|
|||||
|
2021
Q4 | $115K | Hold |
|
|||||
|
2021
Q3 | $129K | Sell |
|
|||||
|
2021
Q2 | $145K | Hold |
|
|||||
|
2021
Q1 | $145K | Hold |
|
|||||
|
2020
Q4 | $150K | Hold |
|
|||||
|
2020
Q3 | $119K | Hold |
|
|||||
|
2020
Q2 | $120K | Sell |
|
|||||
|
2020
Q1 | $89K | Sell |
|
|||||
|
2019
Q4 | $120K | Buy |
|